http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 22 Dec 2025 07:30:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html <p>EMERYVILLE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock:</p> <p>Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.</p> <p>Holders of depositary shares, each representing 1/1000 of a share of XOMA Royalty’s 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO), shall receive a cash dividend equal to $0.52344 per depositary http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html Mon, 22 Dec 2025 07:30:00 -0500 XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html <p>EMERYVILLE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock:</p> <p>Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.</p> <p>Holders of depositary shares, each representing 1/1000 of a share of XOMA Royalty’s 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO), shall receive a cash dividend equal to $0.52344 per depositary http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html Mon, 22 Dec 2025 07:30:00 -0500 XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html <p>EMERYVILLE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock:</p> <p>Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.</p> <p>Holders of depositary shares, each representing 1/1000 of a share of XOMA Royalty’s 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO), shall receive a cash dividend equal to $0.52344 per depositary http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html Mon, 22 Dec 2025 07:30:00 -0500 XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html <p>EMERYVILLE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock:</p> <p>Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.</p> <p>Holders of depositary shares, each representing 1/1000 of a share of XOMA Royalty’s 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO), shall receive a cash dividend equal to $0.52344 per depositary http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html Mon, 22 Dec 2025 07:30:00 -0500 XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html <p>EMERYVILLE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock:</p> <p>Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.</p> <p>Holders of depositary shares, each representing 1/1000 of a share of XOMA Royalty’s 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO), shall receive a cash dividend equal to $0.52344 per depositary http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html Mon, 22 Dec 2025 07:30:00 -0500 XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html <p>EMERYVILLE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock:</p> <p>Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.</p> <p>Holders of depositary shares, each representing 1/1000 of a share of XOMA Royalty’s 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO), shall receive a cash dividend equal to $0.52344 per depositary http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25767624.html Mon, 22 Dec 2025 07:30:00 -0500 XOMA XOMAO XOMAP http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html <p>XOMA Royalty Corporation (NASDAQ: XOMA) extended its tender offer to acquire all outstanding shares of LAVA Therapeutics N.V. (NASDAQ: LVTX) until October 17, 2025, the companies announced.</p> <p>The offer was originally scheduled to expire October 3, 2025. Under the terms, LAVA shareholders would receive a cash amount plus a contingent value right representing 75% of net proceeds from LAVA's two partnered assets and 75% of proceeds from any licensing or sale of unpartnered programs.</p> <p>The proposed acquisition is expected to close in the fourth quarter of 2025, subject to customary closing conditions. LAVA shareholders who previously tendered their shares do not need http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html Thu, 02 Oct 2025 16:43:40 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html <p>XOMA Royalty Corporation (NASDAQ: XOMA) extended its tender offer to acquire all outstanding shares of LAVA Therapeutics N.V. (NASDAQ: LVTX) until October 17, 2025, the companies announced.</p> <p>The offer was originally scheduled to expire October 3, 2025. Under the terms, LAVA shareholders would receive a cash amount plus a contingent value right representing 75% of net proceeds from LAVA's two partnered assets and 75% of proceeds from any licensing or sale of unpartnered programs.</p> <p>The proposed acquisition is expected to close in the fourth quarter of 2025, subject to customary closing conditions. LAVA shareholders who previously tendered their shares do not need http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html Thu, 02 Oct 2025 16:43:40 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html <p>XOMA Royalty Corporation (NASDAQ: XOMA) extended its tender offer to acquire all outstanding shares of LAVA Therapeutics N.V. (NASDAQ: LVTX) until October 17, 2025, the companies announced.</p> <p>The offer was originally scheduled to expire October 3, 2025. Under the terms, LAVA shareholders would receive a cash amount plus a contingent value right representing 75% of net proceeds from LAVA's two partnered assets and 75% of proceeds from any licensing or sale of unpartnered programs.</p> <p>The proposed acquisition is expected to close in the fourth quarter of 2025, subject to customary closing conditions. LAVA shareholders who previously tendered their shares do not need http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html Thu, 02 Oct 2025 16:43:40 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html <p>XOMA Royalty Corporation (NASDAQ: XOMA) extended its tender offer to acquire all outstanding shares of LAVA Therapeutics N.V. (NASDAQ: LVTX) until October 17, 2025, the companies announced.</p> <p>The offer was originally scheduled to expire October 3, 2025. Under the terms, LAVA shareholders would receive a cash amount plus a contingent value right representing 75% of net proceeds from LAVA's two partnered assets and 75% of proceeds from any licensing or sale of unpartnered programs.</p> <p>The proposed acquisition is expected to close in the fourth quarter of 2025, subject to customary closing conditions. LAVA shareholders who previously tendered their shares do not need http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html Thu, 02 Oct 2025 16:43:40 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html <p>XOMA Royalty Corporation (NASDAQ: XOMA) extended its tender offer to acquire all outstanding shares of LAVA Therapeutics N.V. (NASDAQ: LVTX) until October 17, 2025, the companies announced.</p> <p>The offer was originally scheduled to expire October 3, 2025. Under the terms, LAVA shareholders would receive a cash amount plus a contingent value right representing 75% of net proceeds from LAVA's two partnered assets and 75% of proceeds from any licensing or sale of unpartnered programs.</p> <p>The proposed acquisition is expected to close in the fourth quarter of 2025, subject to customary closing conditions. LAVA shareholders who previously tendered their shares do not need http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html Thu, 02 Oct 2025 16:43:40 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html <p>XOMA Royalty Corporation (NASDAQ: XOMA) extended its tender offer to acquire all outstanding shares of LAVA Therapeutics N.V. (NASDAQ: LVTX) until October 17, 2025, the companies announced.</p> <p>The offer was originally scheduled to expire October 3, 2025. Under the terms, LAVA shareholders would receive a cash amount plus a contingent value right representing 75% of net proceeds from LAVA's two partnered assets and 75% of proceeds from any licensing or sale of unpartnered programs.</p> <p>The proposed acquisition is expected to close in the fourth quarter of 2025, subject to customary closing conditions. LAVA shareholders who previously tendered their shares do not need http://www.streetinsider.com/Mergers+and+Acquisitions/XOMA+extends+LAVA+acquisition+tender+offer+to+October+17/25413869.html Thu, 02 Oct 2025 16:43:40 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html <p>EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today announced the extension of the expiration of the tender offer to purchase all outstanding shares of common shares of LAVA, for (i) a cash amount to be determined in accordance with the Purchase Agreement, plus (ii) a non-transferable contingent value right (“CVR”) per share representing the right to receive 75% of the net proceeds related to LAVA’s two partnered assets and 75% of any net proceeds from any out http://www.streetinsider.com/Globe+Newswire/XOMA+Royalty+Extends+Tender+Offer+to+Acquire+LAVA+Therapeutics+N.V./25413865.html Thu, 02 Oct 2025 16:43:00 -0500 LVTX O.00036195 O.26761361 XOMA XOMAO XOMAP http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25358175.html <p align="left">EMERYVILLE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock:  </p> <p>Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.  </p> <p>Holders of depositary shares, each representing 1/1000 of a share of XOMA Royalty’s 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: XOMAO), shall receive a cash dividend equal to $0.52344 per depositary share.  </p> <p>The http://www.streetinsider.com/Press+Releases/XOMA+Royalty+Declares+Quarterly+Preferred+Stock+Dividends/25358175.html Mon, 22 Sep 2025 07:30:00 -0500 XOMA XOMAO XOMAP